Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy (MYOMEX)
Ulipristal Versus Gonadotropin-releasing Hormone Agonists Prior to Laparoscopic Myomectomy: a Double Blind Randomized Controlled Trial
Sponsor: Amsterdam UMC, location VUmc
This PHASE4 trial investigates Fibroids and is currently ongoing. Amsterdam UMC, location VUmc leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jan 2021 — May 2022 [monthly]
Unknown Status PHASE4
▶ Show 3 earlier versions
-
Dec 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
For direct contact, visit the study record on ClinicalTrials.gov .